CRBU vs. QS
CRBU (Caribou Biosciences, Inc.) and QS (QuantumScape Corporation) are both stocks. CRBU operates in Biotechnology (Healthcare), while QS operates in Auto Parts (Consumer Cyclical). Over the past 3 years, CRBU returned -25.26%/yr vs 9.57%/yr for QS. At a 0.44 correlation, their price movements are largely independent.
Performance
CRBU vs. QS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRBU achieves a 25.79% return, which is significantly higher than QS's -15.93% return.
CRBU
- 1D
- -13.79%
- 1M
- 4.71%
- YTD
- 25.79%
- 6M
- 7.53%
- 1Y
- 90.48%
- 3Y*
- -25.26%
- 5Y*
- —
- 10Y*
- —
QS
- 1D
- -4.78%
- 1M
- 21.84%
- YTD
- -15.93%
- 6M
- -29.41%
- 1Y
- 114.18%
- 3Y*
- 9.57%
- 5Y*
- -21.06%
- 10Y*
- —
CRBU vs. QS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
CRBU Caribou Biosciences, Inc. | 25.79% | 0.00% | -72.25% | -8.76% | -58.38% | -7.54% |
QS QuantumScape Corporation | -15.93% | 100.77% | -25.32% | 22.57% | -74.45% | -1.11% |
Correlation
The correlation between CRBU and QS is 0.36, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.36 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.40 |
Correlation (All Time) Calculated using the full available price history since Jul 26, 2021 | 0.44 |
Fundamentals
CRBU:
$191.72M
QS:
$5.35B
CRBU:
-$1.41
QS:
-$0.72
CRBU:
1.88
QS:
4.82
CRBU:
$8.81M
QS:
$0.00
CRBU:
$7.49M
QS:
-$49.03M
CRBU:
-$115.23M
QS:
-$378.92M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRBU vs. QS — Risk / Return Rank
CRBU
QS
CRBU vs. QS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Caribou Biosciences, Inc. (CRBU) and QuantumScape Corporation (QS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CRBU | QS | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.09 | 1.12 | -0.03 |
Sortino ratioReturn per unit of downside risk | 1.92 | 2.22 | -0.30 |
Omega ratioGain probability vs. loss probability | 1.22 | 1.26 | -0.04 |
Calmar ratioReturn relative to maximum drawdown | 1.78 | 1.70 | +0.08 |
Martin ratioReturn relative to average drawdown | 3.15 | 2.69 | +0.45 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CRBU | QS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.09 | 1.12 | -0.03 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | -0.25 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.41 | -0.02 | -0.39 |
Drawdowns
CRBU vs. QS - Drawdown Comparison
The maximum CRBU drawdown since its inception was -97.58%, roughly equal to the maximum QS drawdown of -97.36%. Use the drawdown chart below to compare losses from any high point for CRBU and QS.
Loading charts...
Drawdown Indicators
| CRBU | QS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.58% | -97.36% | -0.22% |
Max Drawdown (1Y)Largest decline over 1 year | -51.06% | -67.68% | +16.62% |
Max Drawdown (3Y)Largest decline over 3 years | -91.12% | -73.93% | -17.19% |
Max Drawdown (5Y)Largest decline over 5 years | — | -91.45% | — |
Current DrawdownCurrent decline from peak | -93.40% | -93.35% | -0.05% |
Average DrawdownAverage peak-to-trough decline | -79.27% | -85.54% | +6.27% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 28.84% | 42.53% | -13.69% |
Volatility
CRBU vs. QS - Volatility Comparison
The current volatility for Caribou Biosciences, Inc. (CRBU) is 21.48%, while QuantumScape Corporation (QS) has a volatility of 22.76%. This indicates that CRBU experiences smaller price fluctuations and is considered to be less risky than QS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CRBU | QS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 21.48% | 22.76% | -1.28% |
Volatility (6M)Calculated over the trailing 6-month period | 49.24% | 45.95% | +3.29% |
Volatility (1Y)Calculated over the trailing 1-year period | 83.67% | 102.34% | -18.67% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 86.84% | 85.62% | +1.22% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 86.84% | 105.90% | -19.06% |
Dividends
CRBU vs. QS - Dividend Comparison
Neither CRBU nor QS has paid dividends to shareholders.
Financials
CRBU vs. QS - Financials Comparison
This section allows you to compare key financial metrics between Caribou Biosciences, Inc. and QuantumScape Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CRBU and QS have a correlation of 0.36, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
QS has higher volatility (22.76%) compared to CRBU (21.48%). In terms of maximum drawdown, CRBU dropped -97.58% vs QS's -97.36%.
QS currently has the higher Sharpe Ratio (1.12 vs 1.09), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CRBU and QS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer